3eqp: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3eqp.png|left|200px]] | [[Image:3eqp.png|left|200px]] | ||
{{STRUCTURE_3eqp| PDB=3eqp | SCENE= }} | {{STRUCTURE_3eqp| PDB=3eqp | SCENE= }} | ||
===Crystal Structure of Ack1 with compound T95=== | ===Crystal Structure of Ack1 with compound T95=== | ||
{{ABSTRACT_PUBMED_18993068}} | {{ABSTRACT_PUBMED_18993068}} | ||
==About this Structure== | ==About this Structure== | ||
[[3eqp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EQP OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018993068</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
| Line 30: | Line 18: | ||
[[Category: Wang, Z.]] | [[Category: Wang, Z.]] | ||
[[Category: Ack1]] | [[Category: Ack1]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Cell membrane]] | [[Category: Cell membrane]] | ||
| Line 39: | Line 26: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Sh3 domain]] | [[Category: Sh3 domain]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
Revision as of 16:36, 6 February 2013
Crystal Structure of Ack1 with compound T95Crystal Structure of Ack1 with compound T95
Template:ABSTRACT PUBMED 18993068
About this StructureAbout this Structure
3eqp is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Kopecky DJ, Hao X, Chen Y, Fu J, Jiao X, Jaen JC, Cardozo MG, Liu J, Wang Z, Walker NP, Wesche H, Li S, Farrelly E, Xiao SH, Kayser F. Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6352-6. Epub 2008 Nov 1. PMID:18993068 doi:10.1016/j.bmcl.2008.10.092